Jordan’s theranostics journey

Follow Jordan on his prostate cancer journey

¹Key statistics for prostate cancer: Prostate cancer facts. Prostate Cancer Facts | American Cancer Society. (n.d.). Available at https://www.cancer.org/cancer/types/prostate-cancer/about/key-statistics.html#:~:text=About%201%20in%2044%20men,point%20are%20still%20alive%20today.

²Novartis. Understanding Metastatic Castration-Resistant Prostate Cancer. Available at https://www.us.pluvicto.com/about-metastatic-castration-resistant-prostate-cancer/understanding-metastatic-prostate-cancer/.

³Data courtesy of Rome Imaging Center, Rome, Georgia, USA.

⁴Products and features mentioned herein are not commercially available in all countries. Future availability cannot be guaranteed.

⁵Novartis. FDA approves Novartis radioligand therapy Pluvicto® for earlier use before chemotherapy in PSMA-positive metastatic castration-resistant prostate cancer. Available at https://www.novartis.com/news/media-releases/fda-approves-novartis-radioligand-therapy-pluvicto-earlier-use-chemotherapy-psma-positive-metastatic-castration-resistant-prostate-cancer.

⁶Data courtesy of Nebraska Cancer Specialists, Omaha, Nebraska, USA.

⁷Data courtesy of Osaka City University Hospital, Osaka, Japan.

⁸Every Symbia Pro.specta configuration produces the highest image quality in its class. Based on competitive literature available at time of publication. Data on file.